Literature DB >> 26205393

Cancer of the prostate: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

C Parker1, S Gillessen2, A Heidenreich3, A Horwich4.   

Abstract

Mesh：

Year:  2015        PMID： 26205393     DOI： 10.1093/annonc/mdv222

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  125 in total

1.  Improved survival with the addition of radiotherapy to androgen deprivation: questions answered and a review of current controversies in radiotherapy for non-metastatic prostate cancer.

Authors:  Arya Amini; Brian D Kavanagh; Chad G Rusthoven
Journal:  Ann Transl Med       Date:  2016-01

2.  Effects of high-intensity interval training compared with resistance training in prostate cancer patients undergoing radiotherapy: a randomized controlled trial.

Authors:  Gilles Caty; Gregory Reychler; Elise Piraux; Laurette Renard; David Vancraeynest; Bertrand Tombal; Xavier Geets
Journal:  Prostate Cancer Prostatic Dis       Date:  2020-07-27       Impact factor: 5.554

3.  PSA response to cabazitaxel is associated with improved progression-free survival in metastatic castration-resistant prostate cancer: the non-interventional QoLiTime study.

Authors:  Peter Hammerer; Salah-Eddin Al-Batran; Christine Windemuth-Kieselbach; Martin Keller; Ralf-Dieter Hofheinz
Journal:  World J Urol       Date:  2018-01-05       Impact factor: 4.226

4.  Followup imaging studies in metastatic castration-resistant prostate cancer: An individualized approach.

Authors:  Myuran Thana; Lori A Wood
Journal:  Can Urol Assoc J       Date:  2019-06       Impact factor: 1.862

Review 5.  Biomarkers for the Management of Castration-Resistant Prostate Cancer: We Are Not There Yet.

Authors:  Daniel P Petrylak; E David Crawford
Journal:  Target Oncol       Date:  2017-08       Impact factor: 4.493

6.  Quality of Cancer Surveillance Clinical Practice Guidelines: Specificity and Consistency of Recommendations.

Authors:  Ryan P Merkow; Deborah Korenstein; Rubaya Yeahia; Peter B Bach; Shrujal S Baxi
Journal:  JAMA Intern Med       Date:  2017-05-01       Impact factor: 21.873

7.  Cost-effectiveness of MR Imaging-guided Strategies for Detection of Prostate Cancer in Biopsy-Naive Men.

Authors:  Shivani Pahwa; Nicholas K Schiltz; Lee E Ponsky; Ziang Lu; Mark A Griswold; Vikas Gulani
Journal:  Radiology       Date:  2017-05-17       Impact factor: 11.105

Review 8.  Prostate-Specific Membrane Antigen-Targeted Radiohalogenated PET and Therapeutic Agents for Prostate Cancer.

Authors:  Steven P Rowe; Alexander Drzezga; Bernd Neumaier; Markus Dietlein; Michael A Gorin; Michael R Zalutsky; Martin G Pomper
Journal:  J Nucl Med       Date:  2016-10       Impact factor: 10.057

Review 9.  Immunobiology and immunotherapy in genitourinary malignancies.

Authors:  Marinos Tsiatas; Petros Grivas
Journal:  Ann Transl Med       Date:  2016-07

Review 10.  Diagnostic imaging to detect and evaluate response to therapy in bone metastases from prostate cancer: current modalities and new horizons.

Authors:  Laura Evangelista; Francesco Bertoldo; Francesco Boccardo; Giario Conti; Ilario Menchi; Francesco Mungai; Umberto Ricardi; Emilio Bombardieri
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-03-09       Impact factor: 9.236
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.